A Predictive Model for an Assistant System to identify Diabetes Mellitus

Elena Fabiola Ruiz-Ledesma, Laura Ivoone Garay-Jiménez, Elizabeth Acosta-Gonzaga


Given the high incidence in Mexico of Diabetes Mellitus (DM), it seems impossible for all patients to be monitored by a specialist. Therefore, preventive action and primary care contact services are an urgent need for early detection of this disease. This paper aims at proposing a model to calculate the risk factor from the information provided by the participant without requiring clinical studies. Firstly, the principal causes of DM are identified via an initial state-of-art analysis about DM pre-screening, screening, diagnosis, and treatment. Then, a digital survey was applied to a sample of fifty participants, all of whom were asked about their knowledge of DM’s causes. Afterward, an in-depth qualitative analysis of the answers was made. Results showed that only 36% of the interviewed subjects identified the main symptoms of DM, but 66% would be willing to consult with a doctor if they could identify the symptoms. The proposed digital system measures the perception of the user and provides quick information about the disease, considering DM Type 1 statistics. The system is based on conditional probability and clinic guides for prevention by identifying risk factors and pondering. Further extensive use of this assistance could raise awareness about the risk factor and provided a percentage of the probability of having DM Type 1, and the result could help detect DM in the early stages.


Predictive model; probability; chronic degenerative illness; early detection.

Full Text:



A. M. Egan and S. F. Dinneen, “What is diabetes?,†Medicine (Baltimore)., vol. 47, no. 1, pp. 1–4, 2019.

A. D. Association, “2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018,†Diabetes Care, vol. 41, no. Supplement 1, pp. S13–S27, 2018.

L. P. Nandhini, S. Kamalanathan, and J. Sahoo, “Definition, Diagnostic Criteria, Screening, Diagnosis, and Classification of Diabetes and Categories of Glucose Intolerance,†in The Diabetes Textbook, Springer, 2019, pp. 71–85.

E. W. Gregg and P. Bracco, “The Dynamics of Diabetes Prevalence, Morbidity, and Mortality,†in The Diabetes Textbook, Springer, 2019, pp. 11–21.

J.-M. Ekoe, R. Goldenberg, and P. Katz, “Screening for diabetes in adults,†Can. J. diabetes, vol. 42, pp. S16–S19, 2018.

L. E. Moore, “Screening, Diagnosis, and Management of Gestational Diabetes,†in Diabetes in Pregnancy, Springer, 2018, pp. 45–59.

R. Rojas-Martínez, A. Basto-Abreu, C. A. Aguilar-Salinas, E. Zárate-Rojas, S. Villalpando, and T. Barrientos-Gutiérrez, “Prevalencia de diabetes por diagnóstico médico previo en México,†Salud Publica Mex., vol. 60, no. 3, pp. 224–232, 2018.

C. B. Williams, D. Y. LaCoursiere, G. A. Talavera, and S. Gahagan, “A feasibility study to promote optimal weight in first time pregnant mothers and their babies: lessons learned in a US-Mexico border community,†Matern. Child Health J., vol. 23, no. 5, pp. 578–584, 2019.

T. C. Aburto, J. M. Poti, and B. M. Popkin, “Patterns and trends in the intake distribution of manufactured and homemade sugar-sweetened beverages in pre-tax Mexico, 1999–2012,†Public Health Nutr., vol. 21, no. 18, pp. 3296–3306, 2018.

A. Arredondo, E. Orozco, M. B. Duarte, S. M. Cuadra, A. L. Recamán, and A. Azar, “Economic Costs, from Individuals to Health Systems: Evidence from a Middle-Income Country,†in The Diabetes Textbook, Springer, 2019, pp. 23–32.

J. R. B. Evia, “México y el reto de las enfermedades crónicas no transmisibles. El laboratorio también juega un papel importante,†Rev. Mex. Patol. Clínica y Med. Lab., vol. 65, no. 1, pp. 4–17, 2018.

E. Y. Mendoza-López, V. Zavala-Ibarra, M. V. Sánchez-González, S. M. López-Correa, and J. Carranza-Madrigal, “Detección de diabetes mellitus en adolescentes con sobrepeso y obesidad,†Med. Interna México, vol. 32, no. 1, pp. 9–13, 2016.

R. A. Gómez-Díaz et al., “Incidence of type 1 diabetes in Mexico: data from an institutional register 2000–2010,†Diabetes Care, vol. 35, no. 11, pp. e77–e77, 2012.

D. Medina and L. Moreno, Encuesta Nacional de Salud y Nutrición 2018 “Boletín técnico N°-XX-Año-OE,†2019 website [Online]. Available: https://ensanut.insp.mx/

D. Gaytán-Hernández, S. O. Gutiérrez-Enríquez, A. Díaz-Oviedo, C. E. González-Acevedo, M. Miranda-Herrera, and L. E. Hernández-Ibarra, “Escenario futuro de la diabetes mellitus tipo 2 estimado con un modelo de simulación dinámico predictivo,†Rev. Panam. Salud Pública, vol. 41, p. e93, 2018.

A. Izquierdo-Valenzuela, X. Boldo-León, and J. M. Muñoz-Cano, “Riesgo para desarrollar diabetes mellitus tipo 2 en una comunidad rural de Tabasco,†Salud en Tabasco, vol. 16, no. 1, pp. 861–868, 2010.

S. Plan, “2020 – 2030 Strategic Plan for,†2020.

W. Y. Stephanie, C. Hill, M. L. Ricks, J. Bennet, and N. E. Oriol, “The scope and impact of mobile health clinics in the United States: a literature review,†Int. J. Equity Health, vol. 16, no. 1, pp. 1–12, 2017.

O. Y. Bello-Chavolla, R. Rojas-Martinez, C. A. Aguilar-Salinas, and M. Hernández-Avila, “Epidemiology of diabetes mellitus in Mexico,†Nutr. Rev., vol. 75, no. suppl_1, pp. 4–12, 2017.

L. A. DiMeglio, C. Evans-Molina, and R. A. Oram, “Type 1 diabetes,†Lancet, vol. 391, no. 10138, pp. 2449–2462, 2018.

C. T. Ferrara et al., “Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development?,†Diabetes Care, vol. 40, no. 5, pp. 698–701, 2017.

A. Pitchika et al., “Associations of maternal diabetes during pregnancy with overweight in offspring: results from the prospective TEDDY study,†Obesity, vol. 26, no. 9, pp. 1457–1466, 2018.

G. Soto-Estrada, L. Moreno Altamirano, J. J. García-García, I. Ochoa Moreno, and M. Silberman, “Trends in frequency of type 2 diabetes in Mexico and its relationship to dietary patterns and contextual factors,†Gac. Sanit., vol. 32, pp. 283–290, 2018.

A. Fehr, C. Lange, J. Fuchs, H. Neuhauser, and R. Schmitz, “Health monitoring and health indicators in Europe,†pp. 3–21, 2017, doi: 10.17886/RKI-GBE-2017-020.

C. P. R. López et al., “Metabolic syndrome, physical activity and eating habits in school children of the south of Mexico City.,†Invest. Clin., vol. 60, no. 1, pp. 7–19, 2019.

OECD, health at a Glance 2017:Indicators. Paris: OECD, 2017.

S. Social, “Chécate , Mídete , Muévete,†pp. 1–2, 2021.

M. Ã. G. Block, H. R. Morales, L. C. Hurtado, A. Balandrán, E. Méndez, and W. H. Organization, “Mexico: health system review,†2020.

C. R. Valle, A. M. B. Ojeda, and J. R. G. Núñez, “Intervención educativa y valoración familiar de enfermería utilizando el Modelo Calgary en una familia de Culiacán, Sinaloa, México,†Revista de Investigación Transdisciplinaria en Educación, Empresa y Sociedad – ITEES, vol. 3, no. 3, pp 318-335, 2020.

X. Huo et al., “Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study,†lancet Diabetes Endocrinol., vol. 4, no. 2, pp. 115–124, 2016.

A. M. Egan et al., “Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe,†Diabetologia, vol. 60, no. 10, pp. 1913–1921, 2017.

J. A. P. González and A. Vidal-Puig, “Obesity in the Pathophysiology of Diabetes,†in The Diabetes Textbook, Springer, 2019, pp. 185–213.

H. Bang et al., “Development and validation of a patient self-assessment score for diabetes risk,†Ann. Intern. Med., vol. 151, no. 11, pp. 775–783, 2009.

S. A. Rains, M. D. Hingle, M. Surdeanu, D. Bell, and S. Kobourov, “A test of the risk perception attitude framework as a message tailoring strategy to promote diabetes screening,†Health Commun., vol. 34, no. 6, pp. 672–679, 2019.

DOI: http://dx.doi.org/10.18517/ijaseit.12.3.11438


  • There are currently no refbacks.

Published by INSIGHT - Indonesian Society for Knowledge and Human Development